Cargando…
A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP
Purpose. Docetaxel/5-FU/CDDP (DFP) therapy is a useful treatment for advanced esophageal cancer. However, adverse reactions such as chemotherapy-induced nausea and vomiting (CINV) interfere often with continuation of the chemotherapy. We investigated the efficacy of rikkunshito (TJ-43) on CINV. Meth...
Autores principales: | Seike, Junichi, Sawada, Toru, Kawakita, Naoya, Yamamoto, Yota, Yuasa, Yasuhiro, Yamai, Hiromichi, Takachi, Hirokazu, Yoshida, Takahiro, Tangoku, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263686/ https://www.ncbi.nlm.nih.gov/pubmed/22312520 http://dx.doi.org/10.1155/2011/715623 |
Ejemplares similares
-
The effects of the herbal medicine Daikenchuto (TJ-100) after esophageal cancer resection, open-label, randomized controlled trial
por: Nishino, Takeshi, et al.
Publicado: (2017) -
Rikkunshito and Ghrelin
por: Hattori, Tomohisa
Publicado: (2010) -
Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice
por: Azushima, Kengo, et al.
Publicado: (2019) -
Ghrelin Enhancer, the Latest Evidence of Rikkunshito
por: Yamada, Chihiro, et al.
Publicado: (2021) -
The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
por: Ohkawa, K., et al.
Publicado: (1988)